CB Therapeutics News Room

Follow us. We’re making news!

June 15, 2020

CB Therapeutics Ships First Order of Rare Cannabinoids to Colorado Client

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics, Inc. has shipped its first order of rare cannabinoids to a customer in Colorado, marking the company’s first commercial sale. The shipment of the rare cannabinoids will be used for trial formulations of edible products to test consumer acceptance in the market… Read More

June 3, 2020

CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics, Inc. has achieved the first successful biosynthesis of DMT (N,N Dimethyltryptamine) and related tryptamine-based compounds in yeast and has filed a patent on their biosynthetic production process for DMT and related analogs. CB Therapeutics’ development of a DMT production process, and its patent application, closely follows the first biosynthetic production of psilocybin in yeast and the patent application for the process… Read More

April 28, 2020

CB Therapeutics Advances its Intellectual Property Portfolio with New Patent Award for its Bioinformatics Platform

SAN DIEGO–(BUSINESS WIRE)–SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is a leading synthetic biotechnology company focused on the research and development of cellular agriculture for the production of cannabinoids, tryptamines and other therapeutics to advance Neuroscience. CB Therapeutics has been awarded a patent for its Bioinformatics platform for the creation and annotation of libraries of biosynthetic pathway genes from next generation sequencing data… Read More

April 20, 2020

CB Therapeutics Enters into Collaboration Agreement with Cleveland Clinic for the Manufacture of Psilocybin, DMT and MDMA Therapeutic Compounds for Clinical Trials to Treat Depression, Addiction and PTSD

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics, Inc., having achieved the successful biosynthesis of psilocybin, psilocin and other related tryptamine-based compounds, has entered into a Memo of Understanding with the Cleveland Clinic to produce multiple therapeutic tryptamine compounds for clinical trials… Read More

December 4, 2019

CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics, Inc. has achieved the successful biosynthesis of psilocybin, psilocin and related tryptamine-based compounds typically found in plants and fungi and has filed a patent for the production process… Read More

November 14, 2019

CB Therapeutics Continues to Advance its Intellectual Property Portfolio with New Patent Awards

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics has been awarded a patent on Oct 10, 2019, titled “Isolated codon optimized Nucleic Acids”. This patent covers inventions related to the optimization of the entire biosynthetic cannabinoid pathway… Read More

Sept 25, 2019

CB Therapeutics Advances Its Intellectual Property Portfolio for Its Cellular Agriculture Platform with New Patent Applications

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics has developed a patent-pending platform for creating and annotating… Read More

July 11, 2019

CB Therapeutics Achieves Key Production Milestone

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics is an innovative biotechnology company focused on the production of high value molecules, compounds and rare ingredients from simple sugars… Read More

March 20, 2019

CB Therapeutics Secures new Research and Production Facility

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes… Read More

September 28, 2018

As cannabis market heats up, local scientists race to build ‘weed biofactories’

Scientists are hustling on behalf of the weed industry to find new ways to produce the most valuable compounds in marijuana, ditching greenhouses in favor of steel vats… Read More

August 22, 2018

The top 10 startups from Y Combinator’s Demo Day S18 Day 2

Sher Butt, a former lab directory at Steep Hill, saw that cannabinoids were as close to a miracle cure for pain, epilepsy and other chronic conditions as medicine was going to get… Read More

We have advanced the science of Cellular Agriculture to build on its promise to meet the health and wellness needs of mankind.